TAK-071 for Mild Cognitive Impairment and Mild Alzheimer's Disease

Source: https://www.nia.nih.gov/alzheimers/clinical-trials/tak-071-mild-cognitive-impairment-and-mild-alzheimers-disease


Undefined

Purpose: To assess the safety, tolerability, and pharmacokinetics of the experimental drug TAK-071 for mild cognitive impairment and mild Alzheimer's disease.

…

Source: https://www.nia.nih.gov/alzheimers/clinical-trials/tak-071-mild-cognitive-impairment-and-mild-alzheimers-disease


Undefined

Purpose: To assess the safety, tolerability, and pharmacokinetics of the experimental drug TAK-071 for mild cognitive impairment and mild Alzheimer's disease.

…

What Do You Think?

comments

Translate »